XML 131 R52.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
Number of Restricted Shares      
Granted (in shares) 300,000 400,000  
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.36 $ 3.9  
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 670,285    
Vested (in shares) (71,487)    
Unvested, end of period (in shares) 878,860   670,285
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 5.58    
Vested (in USD per share) 6.41    
Unvested, end of period (in USD per share) $ 5.24   $ 5.58
Unamortized compensation expense $ 3,035   $ 2,196
Weighted Average Remaining Amortization Period (Years) 2 years   1 year 7 months 6 days
Restricted Stocks Time Vested      
Number of Restricted Shares      
Granted (in shares) 93,353    
Unvested, end of period (in shares) 370,009    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 5.47    
Unvested, end of period (in USD per share) $ 6.06    
Restricted Stocks Time Vested | Employee      
Number of Restricted Shares      
Granted (in shares) 100,000 100,000  
Restricted Stock, Performance Based | Employee      
Number of Restricted Shares      
Granted (in shares) 200,000 200,000  
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 241,613    
Unvested, end of period (in shares) 241,613   241,613
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.37    
Unvested, end of period (in USD per share) $ 2.37   $ 2.37
Unamortized compensation expense $ 288   $ 340
Weighted Average Remaining Amortization Period (Years) 1 year 7 months 6 days   1 year 9 months 18 days
Restricted Stock And Contingent Restricted Stock | Employee      
Number of Restricted Shares      
Granted (in shares)   100,000  
Performance Based Contingent Shares      
Number of Restricted Shares      
Granted (in shares) 186,709    
Unvested, end of period (in shares) 508,851    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 4.36    
Unvested, end of period (in USD per share) $ 4.65